AzTrials
AzTrials

Cerebellar LesionsNCT04887753

Effect of Variance on Error Correction During Coupling (Cerrebellar Lesions)

A study testing Synchronisation abilities in people with Cerebellar Lesions, run by Hasselt University at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is a case-control study, involving persons with persons with cerebellar lesions and healthy controls. The study contains 1 descriptive and 3 experimental sessions. In the descriptive session, participant's clinical motor and cognitive functions are collected. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Cerebellar Lesions
What is being tested?
Synchronisation abilities
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteBelgium
Study dates
29 Apr 2021to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • diagnosis of cerrebellar lesions
  • walking speed 0.8-1.2m/s, ability to walk for 6 minutes continuously (canes and rollators are permitted)

Who cannot join

  • cognitive impairment impeding understanding of
  • instructions,
  • beat amusia,
  • deafness,
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Peter Feys, prof. dr. contact

+32 11 29 21 23

peter.feys@uhasselt.be

lousin Moumdjian, dr. contact

+32 11 26 93 71

lousin.moumdjian@uhasselt.be

Belgium1 site, 1 recruiting
  • Hôpital Civil Marie Curie

    Lodelinsart, 6042

    Mario Manto, prof. dr., +32 11 26 93 71, mmanto@ulb.ac.be

    Pierre Cabaraux, dr., pierre.cabaraux@chu-charleroi.be

    Recruiting

Other trials in Belgium

About this study

Official title: Understanding the Effect of Variances on Precision in Predictive Coding When Walking to Music and Metronomes in Persons With Cerrebellar Lesions

This study is a case-control study, involving persons with persons with cerebellar lesions and healthy controls. The study contains 1 descriptive and 3 experimental sessions. In the descriptive session, participant's clinical motor and cognitive functions are collected. In the first experimental session, participant's beat perception and synchronisation abilities is examined within a finger tapping paradigm. In the following experimental sessions participants synchronsiation abilities is examined during walking paradigms, to music and metronomes, with period and phase auditory manipulations. In the latter twp sessions, apart from outcome measures of synchronization the following will be collected as well: brain activity using EEG recordings, spatio-temporal gait parameters, perceived fatigue, perceived motivation and perceived speed of walking.

Being tested
Synchronisation abilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Synchronisation abilitiesOther

    The study contains 1 descriptive and 3 experimental sessions. In the descriptive session, participant's clinical motor and cognitive functions are collected. In the first experimental session, participant's beat perception and synchronisation abilities is examined within a finger tapping paradigm. In the following experimental sessions participants synchronsiation abilities is examined during walking paradigms, to music and metronomes, with period and phase auditory manipulations.

Study groups in NCT04887753
Study groupRoleWhat they receive
persons with cerebellar lesionsExperimentalNot described
Receives: Other: Synchronisation abilities
Healthy controlsActive comparatorNot described
Receives: Other: Synchronisation abilities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motricity Index of dorsi flexors, knee extensors and hip flexors

    Muscle weakness

    Measured: baseline

  2. Modified Aschowrth scale Hamstrings, Tricepts Surae, Quadricepts

    Spasticity

    Measured: baseline

  3. Scale for the assessment and rating of ataxia

    ataxia

    Measured: baseline

  4. Dynamic gait index

    dynamic balance

    Measured: baseline

  5. Time up and Go test

    Balance

    Measured: baseline

  6. 6 minute walking test

    gait pattern and endurance

    Measured: baseline

  7. cerebellar affective syndrome test

    cognitive test

    Measured: baseline

  8. Activities-specific balance confidence scale

    rating of balance confidence in performing activities of daily life

    Measured: baseline

  9. Modified fatigue impact scale

    effect of fatigue

    Measured: baseline

  10. Hospital Anxiety and Depression Scale

    determine the levels of anxiety and depression

    Measured: baseline

  11. Dual task questionnaire

    troubles a person have when performing a dual task during daily activity

    Measured: baseline

  12. Perceptual tempo and rhythm judgements

    subjective indications in regards to what the participants hear in terms

    Measured: week 1

  13. Asynchrony

    timing difference between the tap and the beat

    Measured: week 1

  14. 64 channel EEG measurement

    neural correlates of entrainment

    Measured: week 1

  15. Resultant Vector Length

    synchronisation consistency

    Measured: week 1

  16. Resultant Vector Length

    synchronisation consistency

    Measured: week 2

  17. Resultant Vector Length

    synchronisation consistency

    Measured: week 3

  18. Relative phase angle

    asynchrony in time to quantify synchronization accuracy (in degrees and in milliseconds respectively)

    Measured: week 2

  19. Relative phase angle

    asynchrony in time to quantify synchronization accuracy (in degrees and in milliseconds respectively)

    Measured: week 3

Secondary outcomes (16)
  1. Cadencce

    number of steps per minute

    Measured: week 2

  2. Cadencce

    number of steps per minute

    Measured: week 3

  3. Stride length

    distance between consecutive steps (cm)

    Measured: week 2

  4. Stride length

    distance between consecutive steps (cm)

    Measured: week 3

  5. Speed

    gait velocity (m/s)

    Measured: week 2

  6. Speed

    gait velocity (m/s)

    Measured: week 3

  7. Double Support

    time that both legs are in contact with the floor (mseconds)

    Measured: week 2

  8. Double Support

    time that both legs are in contact with the floor (mseconds)

    Measured: week 3

  9. Perceived cognitive and physical fatigue

    A visual analogue scale will be used, and participants will be asked to rate their perceived cognitive and physical fatigue levels before and after each experimental walking conditions

    Measured: week 2

  10. Perceived cognitive and physical fatigue

    A visual analogue scale will be used, and participants will be asked to rate their perceived cognitive and physical fatigue levels before and after each experimental walking conditions

    Measured: week 3

  11. Perceived motivation

    A Likert scale will be used, and participants will be asked to rate their perceived motivation of walking after each experimental walking conditions

    Measured: week 2

  12. Perceived motivation

    A Likert scale will be used, and participants will be asked to rate their perceived motivation of walking after each experimental walking conditions

    Measured: week 3

  13. Perceived walking speed

    A Likert scale will be used, and participants will be asked to rate their perceived walking speed relative to their usual walking after each experimental walking conditions

    Measured: week 2

  14. Perceived walking speed

    A Likert scale will be used, and participants will be asked to rate their perceived walking speed relative to their usual walking after each experimental walking conditions

    Measured: week 3

  15. 64 channel EEG measurement (only conducted in 4 PwMS and HC)

    Neural correlates of entrainment

    Measured: week 2

  16. 64 channel EEG measurement (only conducted in 4 PwMS and HC)

    Neural correlates of entrainment

    Measured: week 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2021
  2. Study start29 Apr 2021
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04887753
Sponsor's protocol ID
CL-Music-001
Status last verified
Apr 2024
First submitted
11 May 2021
Last updated
18 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Baliviera E, Rosso M, Moens B, Poncelet M, Manto M, Cabaraux P, Van Wijmeersch B, Leman M, Feys P, Moumdjian L. Neural and behavioral entrainment to auditory rhythmic perturbations in persons with cerebellar impairment. Cereb Cortex. 2025 Jul 1;35(7):bhaf164. doi: 10.1093/cercor/bhaf164.

    PubMed 40663646
  • Fayyad MBN, Verbiest JR, Ivanova A, Manto M, Moumdjian L. Feature derivation and classification of auditory-motor coupling dynamics in healthy and neurologically impaired adults. PLoS One. 2024 Dec 16;19(12):e0315607. doi: 10.1371/journal.pone.0315607. eCollection 2024.

    PubMed 39680529

Questions about this trial

What is this clinical trial studying?

A study testing Synchronisation abilities in people with Cerebellar Lesions, run by Hasselt University at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Peter Feys, prof. dr. (+32 11 29 21 23, peter.feys@uhasselt.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motricity Index of dorsi flexors, knee extensors and hip flexors (time frame: baseline). The study lists 19 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04887753, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in